Medicines Co launches a tender offer for Targanta Therapeutics Corp


US - Medicines Co acquired all the outstanding common stock of Targanta Therapeutics Corp, a biopharmaceutical company, for $# in cash per share, or a total value of $###.### mil, via a tender offer, including up to $##.### mil

Deal Information

Credit & Investment Research

Market Research

News